total assets (37,426): $1,075.67T
real estate: $448.08T
commodities (7): $217.93T
companies (20,524): $150.54T
currencies (113): $139.35T
govt bonds (177): $117.06T
cryptos (11,260): $2.72T
Advertise
Sign up

Get the App

Scan with your phone to download. 35,000+ assets in your pocket.

Google Play QR code Google Play
App Store

The global leaderboard of wealth: $1.2 Quadrillion of Assets ranked by Market Cap

Companies

Alumis Inc. (ALMS) Discusses Phase IIb LUMUS Trial Results and Subgroup Insights in Type 1 Interferon-Driven Diseases Transcript

By seekingalpha.com · · 1 min read
Alumis Inc. (ALMS) Discusses Phase IIb LUMUS Trial Results and Subgroup Insights in Type 1 Interferon-Driven Diseases Transcript

Alumis Inc. (ALMS) Discusses Phase IIb LUMUS Trial Results and Subgroup Insights in Type 1 Interferon-Driven Diseases Transcript

Read the full article on seekingalpha.com

Comments 0

No comments yet. Be the first to share your thoughts!

← All News articles
—— As Seen On ——